Analysts See More Than 60% Upside For These 4 Biotech Stocks

“Now that the global vaccination drive is in full flight, biotech companies are working on their research and development projects to advance new therapies to cure or moderate other critical diseases,” notes the author of today’s article. Against this backdrop, she highlights four biotech stocks that analysts expect to gain more than 60% in the coming months. For these four biotech stocks, CLICK HERE.